Molecular genetics of Delta, a locus required for ectodermal differentiation in Drosophila

Developmental Genetics
A K AltonM A Muskavitch

Abstract

Delta (Dl) is one of the six known zygotic neurogenic genes, each of which is essential for proper segregation of the embryonic ectoderm into neural and epidermal lineages. Molecular analysis of Dl reveals that it is a transcriptionally complex locus that yields multiple maternal and zygotic transcripts. DNA sequence analysis suggests that the predominant product of the locus is a putative transmembrane protein exhibiting homology to blood coagulation factors and epidermal growth factor of vertebrates. The structure of this product is consistent with the hypothesis that Dl participates in cell-cell interactions that are central to establishment of the epidermal lineage within the developing ectoderm. Genetic analyses demonstrate that Dl mutations can modify the imaginal phenotypes that result from heterozygosity for Notch (N) mutations as well as the interaction between particular alleles of Notch (N) and Enhancer of split [E(spl)], two other members of the neurogenic gene set. Vital interactions also occur between Dl and N. Given the structures of products encoded by N, Dl, and E(spl), we suggest that the synergistic phenotypic interactions observed among mutations in these three loci result from physical, as opposed to regula...Continue Reading

References

Jan 1, 1979·Annual Review of Biochemistry·G Carpenter, S Cohen
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·F S JonesG M Edelman
Jan 1, 1988·Annual Review of Biochemistry·E Ruoslahti
Jan 1, 1987·Annual Review of Biochemistry·G Carpenter
Jul 1, 1986·Genetics·N PerrimonA P Mahowald
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G M Technau, J A Campos-Ortega
Jan 1, 1987·Annual Review of Biochemistry·A G Gilman
May 20, 1988·Cell·B Furie, B C Furie
Feb 1, 1985·Developmental Biology·B G GrimwadeS Artavanis-Tsakonas
Nov 1, 1985·Journal of Neurogenetics·H VässinJ A Campos-Ortega
Jun 1, 1962·Genetics·W J WELSHONS, E S VON HALLE
Mar 1, 1937·Proceedings of the National Academy of Sciences of the United States of America·D F Poulson
Jul 1, 1987·Genetics·H Vässin, J A Campos-Ortega
Mar 1, 1988·Genetics·A de-la-ConchaJ A Campos-Ortega
Sep 1, 1984·Wilhelm Roux's Archives of Developmental Biology·G JürgensH Kluding
Sep 1, 1984·Wilhelm Roux's Archives of Developmental Biology·Volker Hartenstein, Jose A Campos-Ortega
Mar 1, 1983·Wilhelm Roux's Archives of Developmental Biology·Ruth LehmannJosé A Campos-Ortega

❮ Previous
Next ❯

Citations

Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D Lyman, M W Young
Apr 26, 2007·The American Journal of Pathology·Frank BalikoBenjamin A Alman
Mar 5, 2010·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Andrew ShepherdCedric Wesley
Oct 30, 2009·Journal of Neurogenetics·Benjamin Lovegren de BivortYi Zhong
Jul 20, 1999·Molecular and Cellular Biology·C S Wesley
Oct 28, 2016·Pathology International·Kei Sakamoto
Nov 25, 2004·Experimental Cell Research·Kei SakamotoAkira Yamaguchi
Mar 1, 1990·Genes & Development·T XuS Artavanis-Tsakonas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.